In the present study, we chose to use donepezil, a cholinesterase inhibitor that is widely used in the treatment of Alzheimer's disease and is orally active and considered to be safe, with few side effects. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.